Pharma Manufacturing in Focus: From Citrix Challenges to Modern VDI Excellence

For Wiewelhove GmbH, a German pharmaceutical contract manufacturer producing 4.5 billion individual doses annually for major pharma companies, the aging Citrix terminal server environment had become an operational liability. Performance bottlenecks delayed critical manufacturing planning workflows, Microsoft Teams integration issues disrupted communication across distributed facilities, Microsoft’s end-of-support announcements created compliance uncertainty, and unpredictable annual license renegotiations made IT budgeting impossible.

This detailed case study reveals exactly how Wiewelhove, in partnership with Global Information Distribution GmbH, made a strategic transition to Omnissa Horizon and App Volumes for 400 users running 40+ specialized applications—including demanding ERP, DMS, and engineering tools. Within weeks, the team saw noticeably improved application responsiveness for manufacturing-critical workflows, simplified IT administration through centralized app management and fewer required golden images, and the operational peace of mind that comes with a clear, predictable five-year licensing roadmap.

What makes this case study particularly valuable is the regulated industry context. Wiewelhove operates in pharmaceutical manufacturing—a sector where IT infrastructure changes require careful planning, validation, and documented outcomes. This case study shows exactly how a sophisticated enterprise in a highly regulated vertical successfully modernized its VDI infrastructure while maintaining compliance, security, and operational continuity. If you operate in a similar regulated environment and have been hesitant about VDI modernization, this proof point will change your thinking.

Download the complete case study to see how a regulated manufacturing enterprise successfully modernized its infrastructure.